Skip to main content
. 2017 Spring;16(2):619–629.

Figure 6.

Flow Cytometry studies for determination immunoreactivity of DOTA-conjugated antibody. From up to down. Background: Cells + rituximab. Negative control: Cells + Herceptin + anti-human IgG (FC specific)-FITC.

Figure 6

Positive control: Cells + rituximab + anti-human IgG (FC specific)-FITC. Sample test: Cells + DOTA-rituximab + anti-human IgG (FC specific)-FITC